Bosentan Hemihydrate
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
Bosentan Hemihydrate Product Information
Bosentan Hemihydrate is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Bosentan. The product is supplied by Clearsynth under CAT No. CS-O-06171.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Bosentan Hemihydrate
CAT No.
CS-O-06171
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C54H60N10O13S2
Molecular Weight
1121.24
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
Bosentan Hemihydrate is supplied with detailed characterization data compliant with regulatory guideline. Bosentan Hemihydrate can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Bosentan.
Overview
Bosentan is a dual endothelin receptor antagonist important in the treatment of pulmonary artery hypertension (PAH). Bosentan is used to treat pulmonary hypertension by blocking the action of endothelin molecules that would otherwise promote narrowing of
Synonyms
Bosentan Hemihydrate
Application Notes
Bosentan is a dual endothelin receptor antagonist important in the treatment of pulmonary artery hypertension (PAH). Bosentan is used to treat pulmonary hypertension by blocking the action of endothelin molecules that would otherwise promote narrowing of
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.